Literature DB >> 8460494

A unique conformation at the carboxyl terminus of the small hepatitis delta antigen revealed by a specific monoclonal antibody.

S B Hwang1, M M Lai.   

Abstract

Two forms of the hepatitis delta antigen (HDAg), a small (24 kDa) and a large (27 kDa) one, have different functions in the hepatitis delta virus (HDV) replication cycle. The small HDAg trans-activates RNA replication, while the large one inhibits RNA replication. The lack of the trans-acting activity in the large HDAg, even though it contains the complete sequence of small HDAg, suggests that the large HDAg lacks a certain functional conformation. To test such a possibility, monoclonal antibodies (MAbs) were generated from mice immunized with recombinant baculovirus-expressed small HDAg. As expected, most of the MAbs recognized both small and large HDAg. In addition, one MAb (9E4) was obtained which recognized only the small HDAg, but not the large one, in Western blot and immunoprecipitation analysis, suggesting that it recognized an epitope unique to small HDAg. However, MAb 9E4 detected both forms of HDAg in virus-infected cells by immunofluorescence and reacted with TrpE-large HDAg fusion proteins expressed in Escherichia coli, suggesting that this MAb recognizes a conformation-dependent epitope which is not present in the native large HDAg molecule but is detectable in LHDAg when its conformation is altered. The 9E4 epitope was mapped within a region of 32 amino acids at the carboxyl-terminus of small HDAg, indicating that this region contains a unique conformation not present in the native molecule of large HDAg. Since this is the only structure identified that is unique to small HDAg, the C-terminal region may contain the domain associated with the biological activities unique to the small HDAg.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8460494     DOI: 10.1006/viro.1993.1201

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  17 in total

1.  RNA-Dependent replication and transcription of hepatitis delta virus RNA involve distinct cellular RNA polymerases.

Authors:  L E Modahl; T B Macnaughton; N Zhu; D L Johnson; M M Lai
Journal:  Mol Cell Biol       Date:  2000-08       Impact factor: 4.272

2.  Increased RNA editing and inhibition of hepatitis delta virus replication by high-level expression of ADAR1 and ADAR2.

Authors:  Geetha C Jayan; John L Casey
Journal:  J Virol       Date:  2002-04       Impact factor: 5.103

3.  Hepatitis delta virus antigen is methylated at arginine residues, and methylation regulates subcellular localization and RNA replication.

Authors:  Yi-Jia Li; Michael R Stallcup; Michael M C Lai
Journal:  J Virol       Date:  2004-12       Impact factor: 5.103

4.  Different sources of "help" facilitate the antibody response to hepatitis D virus delta antigen.

Authors:  Peter Seizer; Petra Riedl; Jörg Reimann; Reinhold Schirmbeck
Journal:  J Mol Med (Berl)       Date:  2004-11-10       Impact factor: 4.599

5.  Isoprenylation masks a conformational epitope and enhances trans-dominant inhibitory function of the large hepatitis delta antigen.

Authors:  S B Hwang; M M Lai
Journal:  J Virol       Date:  1994-05       Impact factor: 5.103

6.  Hepatitis delta antigen mediates the nuclear import of hepatitis delta virus RNA.

Authors:  H C Chou; T Y Hsieh; G T Sheu; M M Lai
Journal:  J Virol       Date:  1998-05       Impact factor: 5.103

7.  The large delta antigen of hepatitis delta virus potently inhibits genomic but not antigenomic RNA synthesis: a mechanism enabling initiation of viral replication.

Authors:  L E Modahl; M M Lai
Journal:  J Virol       Date:  2000-08       Impact factor: 5.103

8.  Hepatitis delta virus mutant: effect on RNA editing.

Authors:  T T Wu; V V Bichko; W S Ryu; S M Lemon; J M Taylor
Journal:  J Virol       Date:  1995-11       Impact factor: 5.103

9.  Isoprenylation mediates direct protein-protein interactions between hepatitis large delta antigen and hepatitis B virus surface antigen.

Authors:  S B Hwang; M M Lai
Journal:  J Virol       Date:  1993-12       Impact factor: 5.103

10.  Prenylome profiling reveals S-farnesylation is crucial for membrane targeting and antiviral activity of ZAP long-isoform.

Authors:  Guillaume Charron; Melody M H Li; Margaret R MacDonald; Howard C Hang
Journal:  Proc Natl Acad Sci U S A       Date:  2013-06-17       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.